Search research articles
Contact Us
Filters
Showing results (41-50 of 69) with videos related to
Page
of 7
Sort By:
Cancer Chemotherapy and Pharmacology
|
January 18, 2006
Salvage chemotherapy with paclitaxel, ifosfamide, and nedaplatin in patients with urothelial cancer who had received prior cisplatin-based therapy
Nobuo Shinohara, Toru Harabayashi, Shin Suzuki, et al.
Japanese Journal of Clinical Oncology
|
June 26, 2015
Prospective mapping of lymph node metastasis in Japanese patients undergoing radical cystectomy for bladder cancer: characteristics of micrometastasis
Ryuji Matsumoto, Norikata Takada, Takashige Abe, et al.
Urologic Oncology
|
June 15, 2020
Oncologic outcomes of laparoscopic radical nephroureterectomy in conjunction with template-based lymph node dissection: An extended follow-up study
Ryuji Matsumoto, Takashige Abe, Norikata Takada, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 15, 2002
Registration accuracy and possible migration of internal fiducial gold marker implanted in prostate and liver treated with real-time tumor-tracking radiation therapy (RTRT)
Kei Kitamura, Hiroki Shirato, Shinichi Shimizu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 3, 2022
Prognosis by cancer type and incidence of zoledronic acid-related osteonecrosis of the jaw: a single-center retrospective study
Hironobu Hata, Kenji Imamachi, Michihiro Ueda, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
January 14, 2026
Efficacy and risks of drug holiday in the management of medication-related osteonecrosis of the jaw in cancer patients: a single-center retrospective study
Hironobu Hata, Kenji Imamachi, Kazuhito Yoshikawa, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 1, 2022
Response to: Prognosis of metastatic bone cancer and myeloma patients and long‑term risk of medication‑related osteonecrosis of the jaw (MRONJ): some critical points
Hironobu Hata, Kenji Imamachi, Michihiro Ueda, et al.
Japanese Journal of Clinical Oncology
|
June 26, 2018
Outcome and prognostic factors in metastatic urothelial carcinoma patients receiving second-line chemotherapy: an analysis of real-world clinical practice data in Japan
Ryuji Matsumoto, Takashige Abe, Junji Ishizaki, et al.
International Journal of Oncology
|
April 30, 2010
Adrenomedullin antagonist suppresses tumor formation in renal cell carcinoma through inhibitory effects on tumor endothelial cells and endothelial progenitor mobilization
Kunihiko Tsuchiya, Kyoko Hida, Yasuhiro Hida, et al.
The American Journal of Pathology
|
October 31, 2009
Cytogenetic abnormalities of tumor-associated endothelial cells in human malignant tumors
Tomoshige Akino, Kyoko Hida, Yasuhiro Hida, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 69) with videos related to
Sort By:
Page
of 7
Cancer Chemotherapy and Pharmacology
|
January 18, 2006
Salvage chemotherapy with paclitaxel, ifosfamide, and nedaplatin in patients with urothelial cancer who had received prior cisplatin-based therapy
Nobuo Shinohara, Toru Harabayashi, Shin Suzuki, et al.
Japanese Journal of Clinical Oncology
|
June 26, 2015
Prospective mapping of lymph node metastasis in Japanese patients undergoing radical cystectomy for bladder cancer: characteristics of micrometastasis
Ryuji Matsumoto, Norikata Takada, Takashige Abe, et al.
Urologic Oncology
|
June 15, 2020
Oncologic outcomes of laparoscopic radical nephroureterectomy in conjunction with template-based lymph node dissection: An extended follow-up study
Ryuji Matsumoto, Takashige Abe, Norikata Takada, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 15, 2002
Registration accuracy and possible migration of internal fiducial gold marker implanted in prostate and liver treated with real-time tumor-tracking radiation therapy (RTRT)
Kei Kitamura, Hiroki Shirato, Shinichi Shimizu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 3, 2022
Prognosis by cancer type and incidence of zoledronic acid-related osteonecrosis of the jaw: a single-center retrospective study
Hironobu Hata, Kenji Imamachi, Michihiro Ueda, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
January 14, 2026
Efficacy and risks of drug holiday in the management of medication-related osteonecrosis of the jaw in cancer patients: a single-center retrospective study
Hironobu Hata, Kenji Imamachi, Kazuhito Yoshikawa, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 1, 2022
Response to: Prognosis of metastatic bone cancer and myeloma patients and long‑term risk of medication‑related osteonecrosis of the jaw (MRONJ): some critical points
Hironobu Hata, Kenji Imamachi, Michihiro Ueda, et al.
Japanese Journal of Clinical Oncology
|
June 26, 2018
Outcome and prognostic factors in metastatic urothelial carcinoma patients receiving second-line chemotherapy: an analysis of real-world clinical practice data in Japan
Ryuji Matsumoto, Takashige Abe, Junji Ishizaki, et al.
International Journal of Oncology
|
April 30, 2010
Adrenomedullin antagonist suppresses tumor formation in renal cell carcinoma through inhibitory effects on tumor endothelial cells and endothelial progenitor mobilization
Kunihiko Tsuchiya, Kyoko Hida, Yasuhiro Hida, et al.
The American Journal of Pathology
|
October 31, 2009
Cytogenetic abnormalities of tumor-associated endothelial cells in human malignant tumors
Tomoshige Akino, Kyoko Hida, Yasuhiro Hida, et al.
Page
of 7